Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: In her editorial, Dr DeAngelis1 described her experience developing and enforcing JAMA's financial disclosure policy and discussed how, despite extensive efforts at education, some authors still lack clear understanding of JAMA's current disclosure requirements.
The issue of disclosure in publications is very important. Recently, the Federation of American Societies for Experimental Biology (FASEB), representing more than 80 000 biomedical researchers, developed overarching principles and voluntary standards for the conduct and management of academia-industry interactions from the scientists' perspective.2 Several of these recommendations speak to the dissemination of research results. FASEB urges investigators to be aware of and adhere to individual journal policies on disclosure of industry relationships. If the researchers are unclear about these policies, contact with the editor is encouraged.
Brockway LM, Furcht LT. Financial Disclosure Policies of Scientific Publications. JAMA. 2006;296(24):2925-2926. doi:10.1001/jama.296.24.2925